Cathie Wood buys $15.7 million of tumbling tech stock

Full Article
Cathie Wood buys $15.7 million of tumbling tech stock

Cathie Wood, head of Ark Investment Management, has made headlines by purchasing $15.7 million worth of Advanced Micro Devices (AMD) shares after a significant drop in stock price following its earnings report. This move reflects her investment strategy of capitalizing on price declines during earnings season to adjust her portfolio. Despite mixed opinions on her performance, Wood remains committed to investing in breakthrough technologies, particularly in the AI sector.

Wood's investment philosophy emphasizes long-term growth in disruptive fields like artificial intelligence, genomics, and blockchain, despite the inherent volatility. While her flagship fund, the ARK Innovation ETF, has faced challenges and significant outflows, she believes that many of her holdings are now undervalued. The recent purchase of AMD shares, despite its weak revenue guidance, indicates confidence in the company's future potential in the AI chip market.

• Cathie Wood invests heavily in AMD amid stock price decline.

• Wood's focus on AI and disruptive technologies remains steadfast.

Key AI Terms Mentioned in this Article

Artificial Intelligence

Artificial intelligence refers to the simulation of human intelligence in machines, which is a key focus for Wood's investments.

Disruptive Innovation

Disruptive innovation involves new technologies that significantly alter industries, which Wood prioritizes in her investment strategy.

AI Chips

AI chips are specialized hardware designed to accelerate AI applications, relevant to AMD's product offerings.

Companies Mentioned in this Article

Advanced Micro Devices

AMD is a semiconductor company that produces processors and AI chips, crucial for the tech industry's growth.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics